OVARIAN CANCER STAGE IV

This adverse event was reported 418 times

These drugs are most commonly taken by patients reporting OVARIAN CANCER STAGE IV:

# Drug Count
0 CARBOPLATIN 18
1 LETROZOLE 17
2 RANITIDINE 17
3 LETROZOLE TABLETS 16
4 PACLITAXEL 16
5 BEVACIZUMAB 15
6 NIRAPARIB 15
7 PACLITAXEL (AIBUMIN-BOUND) 15
8 OLAPARIB 10
9 INTERFERON BETA-1A 8
See all common drugs associated with OVARIAN CANCER STAGE IV

OVARIAN CANCER STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OLIPUDASE ALFA-RPCP 1 0.0073
1 BELINOSTAT 1 0.0028
2 NIRAPARIB 15 0.0007
3 TOPOTECAN 4 0.0007
4 MIRVETUXIMAB SORAVTANSINE 1 0.0006
5 OLAPARIB 10 0.0005
6 TRABECTEDIN 1 0.0004
7 CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN 1 0.0004
8 CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN 1 0.0004
9 PYRIDOXINE HYDROCHLORIDE 1 0.0004
See all drugs enriched for association with OVARIAN CANCER STAGE IV